Tytuł pozycji:
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00
-
Tytuł:
-
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00
-
Autorzy:
-
Pruneri, Giancarlo
Gray, Kathryn P.
Vingiani, Andrea
Viale, Giuseppe
Curigliano, Giuseppe
Criscitiello, Carmen
Láng, István
Ruhstaller, Thomas
Gianni, Lorenzo
Goldhirsch, Aron
Kammler, Roswitha
Price, Karen N.
Cancello, Giuseppe
Munzone, Elisabetta
Gelber, Richard D.
Regan, Meredith M.
Colleoni, Marco
-
Źródło:
-
Breast Cancer Research and Treatment. July 2016 158(2):323-331
-